Study guide
2.1 HIPAA Privacy Rule & the Public Health Reporting Exception
NCRA Oncology Data Specialist ODS-C
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The ODS-C Exam, the Oncology Data Specialist Profession & Standard Setters
1.1 ODS Exam Structure, Timing, Scoring & 2026 Testing Windows 1.2 From CTR to ODS: The Credential, Eligibility Routes & the Registrar's Role 1.3 Standard-Setting Organizations & the Manuals They Publish
2 Chapter 2: Legal Framework, HIPAA & State Reporting Laws
2.1 HIPAA Privacy Rule & the Public Health Reporting Exception 2.2 HIPAA Security Rule, Safeguards & Breach Notification 2.3 State Mandatory Cancer Reporting Laws & Statutory Authority
3 Chapter 3: Confidentiality, Release of Information, Ethics & Credential Maintenance
3.1 Patient Confidentiality Protocols & Data Access Policies 3.2 Handling Subpoenas, Discovery & Registry Immunity Statutes 3.3 NCRA Code of Ethics & ODS Credential Maintenance
4 Chapter 4: Registry Organization, Staffing & Information Systems
4.1 Types of Cancer Registries, Their Functions & Registry Operating Protocols 4.2 Registry Staffing Formulas, Time Studies & Resource Allocation 4.3 Electronic Registry Systems, Security & Disaster Recovery Planning
5 Chapter 5: Cancer Committee, Cancer Conferences & Quality Improvement
5.1 The Cancer Committee: CoC Standards 2.1–2.4, the CLP & Annual Program Activities 5.2 Multidisciplinary Cancer Case Conferences (CoC Standard 2.5) 5.3 Quality Improvement Principles & CoC Chapter 7 (Standards 7.1–7.3)
6 Chapter 6: CoC Accreditation Standards, NCDB & Data Quality
6.1 CoC Accreditation: Standards Structure, Program Categories & Accreditation Awards 6.2 The National Cancer Database (NCDB), RCRS Submission & CoC Quality Measures 6.3 Quality Control Plans & Audit Techniques (CoC Standard 6.1)
7 Chapter 7: Surveillance Programs, NAACCR Standards, Epidemiology & Statistics
7.1 National Cancer Surveillance Programs: SEER & CDC NPCR 7.2 NAACCR Data Exchange Standards, XML Data Specifications & Registry Certification 7.3 Basic Cancer Epidemiology & Descriptive Statistics 7.4 Basic Statistics: Frequency Distributions, Central Tendency, Risk Ratios & Odds Ratios 7.5 Survival Analysis, Life Tables & Presentation of Registry Data
8 Chapter 8: Medical Terminology, Anatomy & Types of Cancer
8.1 Medical Terminology & Standard Abbreviations for Cancer Abstracting 8.2 Human Anatomy & Physiology for Registrars: Tissues, Organ Walls, Subsites & Lymphatic Drainage 8.3 Types & Characteristics of Cancer: Benign vs. Malignant, Tumor Families, Spread & Precursors
9 Chapter 9: Casefinding & Reportability
9.1 Principles of Casefinding & Facility Reference Dates 9.2 Casefinding Sources: Pathology, Cytology, Disease Index & Logs 9.3 Reportability: What CoC, SEER and NPCR Require, Including Non-Malignant CNS Tumors 9.4 Ambiguous Terminology: Reportable Terms, Cytology, Discrepancies & "References of Last Resort"
10 Chapter 10: Diagnostic Procedures, Pathology Reporting, Lab Methods & Prognostic Indicators
10.1 Diagnostic & Staging Procedures: Imaging, Endoscopy, Biopsy & How They Are Coded 10.2 Pathology Reporting, CAP Cancer Protocols & Electronic Pathology (CoC Standard 5.1) 10.3 Specialty Laboratory Testing Methods: IHC, FISH, PCR/RT-PCR, NGS, Flow Cytometry & Cytogenetics 10.4 Prognostic Indicators & Site-Specific Data Items (SSDIs): HPV, KRAS, HER2 and More
11 Chapter 11: Class of Case, Key Dates & Case Identifiers
11.1 Class of Case, Date of First Contact, Date of Diagnosis & Accession/Sequence Numbers 11.2 Analytic Classes of Case (00, 10–14, 20–22): Definitions & Decision Rules 11.3 Nonanalytic Classes of Case (30–49, 99) & Why Central Registries Need Them
12 Chapter 12: Follow-Up, Vital Status & Recurrence
12.1 Follow-Up Purpose, Active & Passive Methods, and Follow-Up Source Codes 12.2 CoC Standard 6.5 Follow-Up Rates: Windows, Exclusions & Calculations 12.3 Vital Status, Date of Last Contact, Cancer Status & Death Clearance 12.4 Recurrence: Type of First Recurrence [1880], Date of First Recurrence [1860] & Recurrence vs. New Primary
13 Chapter 13: Abstracting, ICD-O-3.2 Site & Histology Coding, and Grade
13.1 The Abstracting Process: Workflow, Source Documents, Timeliness & Text Documentation 13.2 ICD-O-3.2 Topography, Primary Site Rules & Laterality 13.3 ICD-O-3.2 Morphology: Histology, Behavior & the Solid Tumor Histology Rules 13.4 Grade: The Four Time-Specific Grade Items & Site-Specific Grade Tables
14 Chapter 14: Solid Tumor Rules & Hematopoietic Coding Rules
14.1 Solid Tumor Rules: Purpose, Site Groups, Navigation & Timing Principles 14.2 Solid Tumor Rules for Breast, Colon/Rectum & Lung: The Multiple Primary Rules in Order 14.3 Solid Tumor Rules for Head & Neck, Kidney, Urinary, CNS, Melanoma & Other Sites 14.4 Hematopoietic & Lymphoid Neoplasms: Heme Manual, Heme DB, Multiple Primary & Primary Site Rules
15 Chapter 15: Staging: AJCC TNM (8th Edition & Version 9 Lung) and Summary Stage 2018
15.1 AJCC TNM Principles: Categories, Prefixes, Suffixes, General Rules & Registry Items 15.2 AJCC Time Frames: Clinical, Pathological, Post-Therapy (yc, yp), Recurrence & Autopsy 15.3 Breast Staging (AJCC 8th Edition, Part XI): T, N, M, Anatomic & Prognostic Stage Groups 15.4 Lung Staging (AJCC Version 9, 2025+): T, N2a/N2b, M1c1/M1c2 & New Stage Groups 15.5 Male Genital & Urinary Tract Staging (AJCC 8th Parts XIII–XIV): Prostate, Testis, Kidney, Bladder, Renal Pelvis & Ureter 15.6 SEER Summary Stage 2018: Codes, Timing, General Rules & Site Examples
16 Chapter 16: First-Course Treatment Coding (STORE 2025) & EDITS
16.1 Treatment Types, First Course of Treatment & Evidence-Based Guidelines (NCCN) 16.2 Surgery Coding: Rx Summ–Surg 2023 [1291], Lymph Node Surgery [1292], Other Site [1294], Margins & Reason for No Surgery 16.3 Radiation, Systemic, Transplant, Other & Palliative Treatment Coding (STORE 2025) 16.4 NAACCR EDITS, Over-ride Flags & Data Validation
2.1 HIPAA Privacy Rule & the Public Health Reporting Exception
Key Takeaways Explain This Topic AI
Under 45 CFR § 164.512(b), covered entities may disclose Protected Health Information (PHI) to public health authorities without patient consent or authorization.
The HIPAA Privacy Rule defines 18 specific identifiers that transform health data into identifiable PHI under 45 CFR § 164.514.
Disclosures required by law are exempt from the minimum necessary standard, and for other public health disclosures a covered entity may reasonably rely on the public health authority's request as the minimum necessary (45 CFR § 164.502(b) and § 164.514(d)(3)(iii)).
Disclosures to state central cancer registries do not require a Business Associate Agreement (BAA) because central registries function as sovereign public health authorities.
A Business Associate Agreement is legally mandated when engaging external contract abstractors, independent cancer registry software vendors, or cloud hosts.
Last updated: September 2026
2.1 HIPAA Privacy Rule & the Public Health Reporting Exception
Cancer registration relies on the systematic collection of detailed personal, demographic, clinical, and pathological information from individuals diagnosed with neoplastic disease. Because cancer data abstracting involves extensive review of inpatient admissions, outpatient oncology visits, surgical operative notes, pathology reports, and radiation summaries, Oncology Data Specialists (ODS) operate at the direct intersection of patient privacy rights and public health law. Navigating this environment requires mastering the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy Rule, codified in Title 45 of the Code of Federal Regulations (CFR), Parts 160 and 164 .
The HIPAA Privacy Rule: Statutory Architecture
Enacted by Congress in 1996 and implemented through federal regulations issued by the Department of Health and Human Services (HHS), the HIPAA Privacy Rule establishes national standards to protect individuals' medical records and other personal health information. The rule applies to Covered Entities , which include:
Healthcare Providers : Any provider of medical or health services (e.g., hospitals, academic medical centers, ambulatory surgery centers, pathology laboratories, radiation clinics, and individual physicians) who transmits health information electronically in connection with standard transactions.
Health Plans : Health insurance companies, health maintenance organizations (HMOs), Medicare, Medicaid, and employer-sponsored group health plans.
Healthcare Clearinghouses : Entities that process nonstandard health information received from another entity into standard electronic data formats, or vice versa.
In addition to covered entities, HIPAA regulations directly govern Business Associates —external individuals or entities that perform functions or activities on behalf of, or provide services to, a covered entity involving the use or disclosure of protected health information.
Protected Health Information (PHI) & The 18 HIPAA Identifiers
Protected Health Information (PHI) is defined under 45 CFR § 160.103 as individually identifiable health information held or transmitted by a covered entity or its business associate, in any form or media, whether electronic, paper, or oral. It relates to the past, present, or future physical or mental health or condition of an individual, the provision of healthcare to an individual, or the past, present, or future payment for the provision of healthcare.
Under 45 CFR § 164.514(b)(2), health information is rendered non-identifiable only when all 18 HIPAA Identifiers pertaining to the individual, their relatives, employers, or household members are removed, provided the covered entity has no actual knowledge that the remaining information could identify the individual:
- Identifier Number HIPAA Identifier Category Cancer Registry Operational Context
- 1 Names Patient first, middle, last, maiden, and alias names recorded in registry abstracts
2 Geographic Subdivisions Smaller Than a State Street address, city, county, precinct, ZIP code, and equivalent geocodes (census tract, block group)
3 All Dates Directly Related to an Individual Date of birth, date of initial diagnosis, date of first contact, admission/discharge dates, dates of surgery, radiation, systemic therapy, and date of last contact/death (and all ages over 89)
- 4 Telephone Numbers Primary residential, cellular, and emergency contact numbers used for active follow-up
- 5 Fax Numbers Provider and facility facsimile transmission numbers
- 6 Electronic Mail Addresses Patient personal and work email addresses
7 Social Security Numbers (SSN) Patient SSN used for deterministic record linkage and National Death Index (NDI) matching
8 Medical Record Numbers (MRN) Facility-assigned unique patient identifiers within hospital electronic health records (EHR)
- 9 Health Plan Beneficiary Numbers Medicare, Medicaid, or private commercial payer insurance policy numbers
- 10 Account Numbers Hospital billing and patient financial services encounter numbers
- 11 Certificate / License Numbers Driver's license numbers or professional license numbers
12 Vehicle Identifiers and Serial Numbers Automobile license plate numbers and vehicle identification numbers (VINs)
13 Device Identifiers and Serial Numbers Medical device serial numbers (e.g., implanted port serial numbers, pacemaker IDs)
- 14 Web Universal Resource Locators (URLs) Patient or personal website addresses
- 15 Internet Protocol (IP) Address Numbers Network IP addresses captured during patient portal access
- 16 Biometric Identifiers Fingerprints, voiceprints, or retinal scans
- 17 Full-Face Photographic Images Clinical photographs, identification badge photos, or comparable images
18 Any Other Unique Identifying Number, Characteristic or Code Any unique number, characteristic or code, such as a registry accession number; only a re-identification code assigned under 45 CFR § 164.514(c) (not derived from patient information) may remain
For geographic data, the rule permits using the first three digits of a ZIP code if the geographic unit formed by combining all ZIP codes with the same three initial digits contains more than 20,000 individuals; otherwise, the first three digits must be combined into 000.
The Public Health Reporting Exception: 45 CFR § 164.512(b)
A common misunderstanding among healthcare staff and newly credentialed registrars is the belief that patient authorization or written consent is required before cancer data can be collected, abstracted, or transmitted to state authorities. Under federal law, this assumption is completely incorrect.
Congress and HHS recognized that requiring individual patient consent for public health tracking would paralyze epidemiology, obscure disease clusters, and prevent accurate population-level cancer surveillance. Consequently, 45 CFR § 164.512(b) establishes an explicit Public Health Exception to the Privacy Rule.
Core Provisions of 45 CFR § 164.512(b)
Under this statutory provision, covered entities are legally permitted to disclose PHI WITHOUT individual patient authorization, consent, or opportunity to agree or object, to:
"A public health authority that is authorized by law to collect or receive such information for the purpose of preventing or controlling disease, injury, or disability, including, but not limited to, the reporting of disease, injury, vital events such as birth or death, and the conduct of public health surveillance, public health investigations, and public health interventions..."
Legal Classification of State Central Cancer Registries
A Public Health Authority is defined under 45 CFR § 164.501 as an agency or authority of the United States, a State, a territory, a political subdivision of a State or territory, or an Indian tribe, or a person or entity acting under a grant of authority from or contract with such public agency, that is responsible for public health matters as part of its official mandate.
State central cancer registries established pursuant to state reporting statutes qualify unequivocally as public health authorities. Therefore, when a hospital cancer registry, pathology laboratory, or independent abstractor transmits cancer abstracts containing complete patient identifiers (names, SSNs, street addresses, dates of diagnosis) to the state central cancer registry, the transmission is fully authorized under federal law.
The Minimum Necessary Standard & Mandatory Disclosures: 45 CFR § 164.502(b)
The general standard under the HIPAA Privacy Rule is the Minimum Necessary Standard (45 CFR § 164.502(b)). This standard requires that when covered entities use or disclose PHI, or request PHI from another covered entity, they must make reasonable efforts to limit the information to the minimum amount necessary to accomplish the intended purpose.
The Critical Public Health Carve-Out
Many hospital privacy officers mistakenly attempt to redact or withhold names, full street addresses, or Social Security numbers from state cancer registry submissions, citing the Minimum Necessary Standard. However, federal regulations contain two critical exceptions that supersede this restriction:
Disclosures Required by Law (45 CFR § 164.512(a)) : The minimum necessary standard does not apply to disclosures required by state or federal statute.
Disclosures to Public Health Authorities (45 CFR § 164.512(b)) : Under 45 CFR § 164.514(d)(3)(iii)(A), a covered entity may reasonably rely on the representations of the public health authority regarding what information constitutes the minimum necessary for the public health purpose.
Because state cancer reporting statutes and administrative codes mandate the submission of the standardized North American Association of Central Cancer Registries (NAACCR) data item set—which explicitly requires patient names, Social Security numbers, dates, geocodes, and detailed diagnostic text—the covered entity is legally protected in disclosing the entire mandated data set without redaction.
Business Associate Agreements (BAAs) in Cancer Registry Operations
A Business Associate Agreement (BAA) is a binding legal contract required under 45 CFR § 164.502(e) and § 164.504(e) between a covered entity and a business associate. The BAA establishes the permitted and required uses and disclosures of PHI, requires the business associate to implement administrative, physical, and technical safeguards, mandates prompt breach reporting, and extends HIPAA statutory liability directly to the contractor.
Understanding when a BAA is legally required—and when it is legally prohibited or unnecessary—is a frequent test area on the ODS examination.
Operating Entity / Relationship BAA Required? Legal Rationale & Statutory Basis
State Central Cancer Registry NO State central registries are sovereign public health authorities exercising statutory oversight under 45 CFR § 164.512(b). They are not performing a service on behalf of the hospital; therefore, requiring a BAA is inappropriate and legally invalid.
Contract Abstracting Company YES An outsourced abstracting firm or independent credentialed contractor hired by a hospital to abstract cases performs a registry function on behalf of the covered entity under 45 CFR § 160.103. A formal BAA is mandatory prior to granting system access.
Commercial Registry Software Vendor (Cloud / EHR Host) YES Software providers hosting electronic cancer registry databases or cloud servers store, maintain, and transmit ePHI on behalf of the facility. A BAA is federally mandated.
Offsite Data Storage & Document Shredding Services YES Vendors providing physical archive storage, microfiche conversion, digital scanning, or secure destruction of paper oncology records handle PHI on behalf of the covered entity.
Treating Physicians & Consulting Oncologists NO Disclosures between healthcare providers for the purpose of patient treatment (45 CFR § 164.506) do not require a BAA.
Commission on Cancer (CoC) / National Cancer Database (NCDB) YES NCDB submissions are quality-assessment disclosures made under the American College of Surgeons Business Associate/Data Use Agreement that STORE references for accredited programs; the agreement defines how the ACS may use the data.
- Realistic Practice Scenarios & Exam Pitfalls
- Scenario 1: The Patient Consent Refusal
A 58-year-old patient diagnosed with invasive ductal carcinoma of the breast signs a hospital admission document explicitly stating: "I revoke all permissions for my medical records, cancer diagnosis, or treatment records to be shared with any state, government, or external registry database." The hospital compliance officer directs the cancer registry supervisor to withhold the patient's abstract from the state central registry.
Legal Resolution : The compliance officer's instruction violates state mandatory reporting laws. Under 45 CFR § 164.512(b) and state public health statutes, cancer reporting is a non-consensual mandatory duty. An individual patient cannot "opt out" of statutory disease surveillance. The cancer registrar must complete the abstract and transmit the case to the state central registry. The facility faces statutory fines if it complies with the patient's request to withhold the report.
Scenario 2: The BAA Demand to the State Registry
A hospital legal counsel informs the cancer registry department that until the State Department of Health Central Cancer Registry executes the hospital's standardized 15-page Business Associate Agreement, no further electronic monthly batches of cancer abstracts may be uploaded.
Legal Resolution : Hospital legal counsel is incorrect. State central registries operate under sovereign public health authority. They do not work on behalf of the hospital and cannot sign a BAA. Demanding a BAA before releasing mandatory public health data obstructs statutory compliance and risks state regulatory penalties for failure to report within the mandated timeframe.
Exam Pitfall Checklist
Do NOT assume HIPAA restricts state cancer reporting : HIPAA was deliberately structured to facilitate, preserve, and protect public health reporting.
Do NOT confuse research with public health surveillance : Research involving PHI generally requires either patient authorization or a formal waiver of authorization from an Institutional Review Board (IRB) or Privacy Board under 45 CFR § 164.512(i). Mandatory state cancer registry reporting is public health surveillance under § 164.512(b), requiring neither IRB approval nor patient consent.
Do NOT apply Minimum Necessary to state data items : If the state cancer registry manual or NAACCR standard specifies an item (e.g., text justification, full birth dates, street addresses), the facility cannot withhold it under the guise of minimum necessary.